Abstract
The hepatitis C virus (HCV) is a single-stranded enveloped RNA virus, belonging to the Hepacivirus genus within the Flaviviridae family. HCV infection has become a major worldwide health problem because it causes a chronic hepatitis leading to hepatocarcinoma (HCC) and to non-Hodgkins B-cell lymphoma (NHL). The absence of a reliable experimental model, which mimics the physiological effect of HCV infection in human subjects, hampered the analysis of the mechanisms by which HCV leads to cancer. Nevertheless, both in vitro expression systems and in vivo transgenic mice studies suggest that HCV persistent infection in the host is able to induce neoplastic transformation. The oncogenic properties of HCV are often related to the ability of HCV-encoded proteins to interfere with cell signaling through the interaction with different molecules involved in the control of cell proliferation, apoptosis and interferon (IFN)-signaling pathways. The present systematic review will mainly focus on the HCV proteins dependent pathogenetic effects on the most important regulatory proteins of cell homeostasis. Since poor efficacy of the current therapy, studying the mechanisms underlying HCV-induced cell transformation and immune evasion will help researchers to identify new therapeutic targets, which may be useful in the near future to develop more effective and better-tolerated therapies, capable of impairing or reversing the progression of HCV-related tumors.
Keywords: HCV, HCC, HCV-related NHL, IFN, treatment, gene therapy
Current Cancer Therapy Reviews
Title: HCV-Related Transformation and New Therapeutic Strategies: An Update
Volume: 2 Issue: 1
Author(s): Clara Balsano and Anna Alisi
Affiliation:
Keywords: HCV, HCC, HCV-related NHL, IFN, treatment, gene therapy
Abstract: The hepatitis C virus (HCV) is a single-stranded enveloped RNA virus, belonging to the Hepacivirus genus within the Flaviviridae family. HCV infection has become a major worldwide health problem because it causes a chronic hepatitis leading to hepatocarcinoma (HCC) and to non-Hodgkins B-cell lymphoma (NHL). The absence of a reliable experimental model, which mimics the physiological effect of HCV infection in human subjects, hampered the analysis of the mechanisms by which HCV leads to cancer. Nevertheless, both in vitro expression systems and in vivo transgenic mice studies suggest that HCV persistent infection in the host is able to induce neoplastic transformation. The oncogenic properties of HCV are often related to the ability of HCV-encoded proteins to interfere with cell signaling through the interaction with different molecules involved in the control of cell proliferation, apoptosis and interferon (IFN)-signaling pathways. The present systematic review will mainly focus on the HCV proteins dependent pathogenetic effects on the most important regulatory proteins of cell homeostasis. Since poor efficacy of the current therapy, studying the mechanisms underlying HCV-induced cell transformation and immune evasion will help researchers to identify new therapeutic targets, which may be useful in the near future to develop more effective and better-tolerated therapies, capable of impairing or reversing the progression of HCV-related tumors.
Export Options
About this article
Cite this article as:
Balsano Clara and Alisi Anna, HCV-Related Transformation and New Therapeutic Strategies: An Update, Current Cancer Therapy Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339406775471830
DOI https://dx.doi.org/10.2174/157339406775471830 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reposition of the Fungicide Ciclopirox for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Medicinal Plants from Peru: A Review of Plants as Potential Agents Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Novel Intervention Strategies for Helicobacter pylori Treatment
Current Drug Targets - Infectious Disorders Supertargeted Chemistry: Identifying Relationships Between Molecular Structures and their Sub-Cellular Distribution
Current Topics in Medicinal Chemistry Exploring the Chemical Space of P-Glycoprotein Interacting Compounds
Mini-Reviews in Medicinal Chemistry 2-Substituted-5-Nitroheterocycles: In Vitro Anti-Helicobacter pylori Activity and Structure-Activity Relationship Study
Medicinal Chemistry 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors
Recent Patents on Anti-Cancer Drug Discovery HSP-Dependent Protection Against Gastrointestinal Diseases
Current Pharmaceutical Design Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics The Role of Micafungin and Anidulafungin in the Treatment of Systemic Fungal Infections: Applications and Patents for Two Novel Echinocandins
Recent Patents on Anti-Infective Drug Discovery Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Mini-Reviews in Medicinal Chemistry Defensin Participation in Innate and Adaptive Immunity
Current Pharmaceutical Design Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention
Current Cancer Drug Targets Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma Treatment
Recent Patents on Anti-Cancer Drug Discovery Cancer Proteomics: New Horizons and Insights into Therapeutic Applications
Current Proteomics Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy 5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β
Anti-Cancer Agents in Medicinal Chemistry Leveraging Cell Cycle Analysis in Anticancer Drug Discovery to Identify Novel Plasmodial Drug Targets
Infectious Disorders - Drug Targets Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
Current Gene Therapy